Medicine and Dentistry
Colorectal Liver Metastasis
100%
Radiofrequency Ablation
74%
Surgery
55%
Pancreas Cancer
52%
Neoplasm
50%
Pancreaticoduodenectomy
32%
Liver Surgery
31%
Metastatic Carcinoma
29%
Tumor Cell
29%
Overall Survival
28%
Ischemia
28%
Tumor Progression
28%
Clear Cell Renal Cell Carcinoma
28%
Micrometastasis
25%
Liver Metastasis
25%
Hypoxia
24%
Recurrent Disease
24%
Hepatectomy
23%
Pancreatic Surgery
21%
Anemia
19%
Systematic Review
19%
Fas Ligand
19%
Programmed Cell Death
19%
Machine Perfusion
18%
Liver Transplantation
18%
Surgery
18%
Pancreas Adenocarcinoma
18%
Cryoablation
16%
Malignant Neoplasm
15%
Partial Nephrectomy
14%
Tumor Recurrence
14%
Supplementation
14%
Iron Deficiency
14%
Nutritional Support
14%
Disease Free Survival
13%
Clinical Trial
12%
Hepatocellular Carcinoma
12%
Prognostic Factor
12%
Adverse Event
12%
Kidney Tumour
12%
Cohort Analysis
11%
Pancreas Fistula
11%
Colorectal Carcinoma
11%
Irreversible Electroporation
11%
Disease
10%
Liver Tumor
10%
Hemihepatectomy
10%
Colorectal Tumor
10%
Necrosis
10%
Cancer Therapy
9%
Keyphrases
Colorectal Liver Metastases
48%
Radiofrequency Ablation
28%
Pancreaticoduodenectomy
26%
Overall Survival
19%
Resection
19%
Pancreatic Surgery
18%
Prehabilitation
18%
CD95
18%
Pancreatic Ductal Adenocarcinoma
18%
Severe Complications
14%
Micrometastasis
12%
Risk Model
12%
Preoperative Anemia
11%
Oncological Outcomes
11%
CD95L
11%
Irreversible Electroporation
11%
Resectable Pancreatic Cancer
11%
90-day Mortality
11%
Pancreatic Cancer
10%
External Validation
10%
Extended Hemihepatectomy
10%
Anatomic Liver Resection
10%
Postoperative Outcomes
10%
Iron Deficiency
9%
Treatment Allocation
9%
Pancreatic Neuroendocrine Tumors (pNETs)
9%
Resectability
9%
Intravenous Iron Therapy
9%
Team Assessment
9%
Cannabis Products
9%
Complication after Surgery
9%
Robotic Liver Surgery
9%
Risk Factors for Complications
9%
Type 1 Diabetes Mellitus (T1DM)
9%
Todani
9%
Multidisciplinary Team
9%
Poor Prognostic Factors
9%
Long-term Survivors
9%
Multicenter Cohort Study
9%
Mouse Liver
9%
Prognostic Marker
9%
Clinical Outcomes
9%
Renal Cell Carcinoma
9%
Microwave Ablation
9%
Parallel Electrode
9%
Multicenter Randomized Controlled Trial
9%
Two Parallel Plates
9%
Interleukin-2
9%
Surgical Outcomes
9%
Pancreas
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
61%
Colorectal Liver Metastasis
46%
Hypoxia
20%
Tumor Growth
19%
Renal Cell Carcinoma
18%
Interleukin 2
18%
Malignant Neoplasm
18%
Micrometastasis
17%
Ischemia
14%
Recurrent Disease
13%
Colorectal Carcinoma
13%
Colorectal Tumor
13%
Clinical Trial
12%
Pancreas Cancer
11%
Metastasis
11%
Liver Tumor
10%
Gallbladder Cancer
9%
Cannabis
9%
Spleen Abscess
9%
Tirapazamine
9%
Porcine Model
9%
Necrosis
9%
Randomized Controlled Trial
9%
Growth Factor Receptor
9%
Liver Cancer
9%
Tumor Recurrence
9%
Granulocyte Colony Stimulating Factor
9%
Irinotecan
9%
Epidermal Growth Factor Receptor
9%
Fas Ligand
9%
CD8 Antigen
8%
Adverse Event
7%
Liver Metastasis
5%
